Jorma Hassfeld

971 total citations
31 papers, 779 citations indexed

About

Jorma Hassfeld is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Jorma Hassfeld has authored 31 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 10 papers in Molecular Biology and 8 papers in Inorganic Chemistry. Recurrent topics in Jorma Hassfeld's work include Synthetic Organic Chemistry Methods (11 papers), ATP Synthase and ATPases Research (7 papers) and Asymmetric Hydrogenation and Catalysis (7 papers). Jorma Hassfeld is often cited by papers focused on Synthetic Organic Chemistry Methods (11 papers), ATP Synthase and ATPases Research (7 papers) and Asymmetric Hydrogenation and Catalysis (7 papers). Jorma Hassfeld collaborates with scholars based in Germany, Switzerland and Netherlands. Jorma Hassfeld's co-authors include Dirk Menche, Sven Rudolph, Markus Kalesse, Christophe Farès, Teresa Carlomagno, Ulrike Eggert, Jun Li, Heinrich Steinmetz, Helmut Wieczorek and Markus Huss and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Jorma Hassfeld

31 papers receiving 771 citations

Peers

Jorma Hassfeld
Helena M. Lovick United States
Martin A. Berliner United States
William S. Kissel United States
Daqiang Xu United States
Cheol K. Chung United States
Steven M. Mennen United States
Michael A. Calter United States
Helena M. Lovick United States
Jorma Hassfeld
Citations per year, relative to Jorma Hassfeld Jorma Hassfeld (= 1×) peers Helena M. Lovick

Countries citing papers authored by Jorma Hassfeld

Since Specialization
Citations

This map shows the geographic impact of Jorma Hassfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorma Hassfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorma Hassfeld more than expected).

Fields of papers citing papers by Jorma Hassfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorma Hassfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorma Hassfeld. The network helps show where Jorma Hassfeld may publish in the future.

Co-authorship network of co-authors of Jorma Hassfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Jorma Hassfeld. A scholar is included among the top collaborators of Jorma Hassfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorma Hassfeld. Jorma Hassfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krueger, Joachim I., André P. Dieskau, Jorma Hassfeld, et al.. (2025). Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists. Angewandte Chemie International Edition. 64(19). e202420719–e202420719. 2 indexed citations
2.
Verzijl, Gerard K. M., Jorma Hassfeld, André H. M. de Vries, & Laurent Lefort. (2020). Enantioselective Synthesis of a 2,3-Benzodiazepine Intermediate of BET Inhibitor BAY 1238097 via Catalytic Asymmetric Hydrogenation. Organic Process Research & Development. 24(2). 255–260. 11 indexed citations
3.
4.
Hassfeld, Jorma, et al.. (2017). Continuous Platinum‐Mediated Hydrogenation of Refametinib Iodo‐nitroaniline Key Intermediate DIM‐NA: The Combined Challenges of Selectivity and Catalyst Deactivation. European Journal of Organic Chemistry. 2017(27). 3921–3928. 4 indexed citations
5.
Hassfeld, Jorma, et al.. (2016). Encapsulated Cobalt Oxide on Carbon Nanotube Support as Catalyst for Selective Continuous Hydrogenation of the Showcase Substrate 1‐Iodo‐4‐nitrobenzene. Advanced Synthesis & Catalysis. 358(18). 2903–2911. 23 indexed citations
6.
Hassfeld, Jorma, et al.. (2015). Selective Hydrogenation of Halogenated Nitroaromatics to Haloanilines in Batch and Flow. Organic Process Research & Development. 20(2). 452–464. 51 indexed citations
7.
Graham, Keith, Ralf Lesche, Niels Böhnke, et al.. (2012). Radiofluorinated Derivatives of 2-(Phosphonomethyl)pentanedioic Acid as Inhibitors of Prostate Specific Membrane Antigen (PSMA) for the Imaging of Prostate Cancer. Journal of Medicinal Chemistry. 55(22). 9510–9520. 27 indexed citations
8.
Farès, Christophe, Jorma Hassfeld, Dirk Menche, & Teresa Carlomagno. (2008). Simultaneous Determination of the Conformation and Relative Configuration of Archazolide A by Using Nuclear Overhauser Effects, J Couplings, and Residual Dipolar Couplings. Angewandte Chemie International Edition. 47(20). 3722–3726. 61 indexed citations
9.
Hassfeld, Jorma, et al.. (2007). The Total Synthesis of (+)‐Tedanolide—A Macrocyclic Polyketide from Marine Sponge Tedania ignis. Chemistry - A European Journal. 14(7). 2232–2247. 37 indexed citations
10.
Menche, Dirk, Jorma Hassfeld, Heinrich Steinmetz, et al.. (2007). Archazolid‐7‐O‐β‐D‐glucopyranoside – Isolation, Structural Elucidation and Solution Conformation of a Novel V‐ATPase Inhibitor from the Myxobacterium Cystobacter violaceus. European Journal of Organic Chemistry. 2007(7). 1196–1202. 23 indexed citations
11.
Menche, Dirk, Jorma Hassfeld, Heinrich Steinmetz, et al.. (2007). The First Hydroxylated Archazolid from the Myxobacterium Cystobacter violaceus: Isolation, Structural Elucidation and V-ATPase Inhibition. The Journal of Antibiotics. 60(5). 328–331. 26 indexed citations
12.
Menche, Dirk, et al.. (2007). Total Synthesis of Archazolid A. Journal of the American Chemical Society. 129(19). 6100–6101. 74 indexed citations
13.
Menche, Dirk, Jorma Hassfeld, Jun Li, & Sven Rudolph. (2007). Synthesis of Archazolid A. Synfacts. 2007(10). 1016–1016. 6 indexed citations
14.
Menche, Dirk, Jorma Hassfeld, Florenz Sasse, Markus Huss, & Helmut Wieczorek. (2006). Design, synthesis, and biological evaluation of novel analogues of archazolid: A highly potent simplified V-ATPase inhibitor. Bioorganic & Medicinal Chemistry Letters. 17(6). 1732–1735. 33 indexed citations
15.
Menche, Dirk, et al.. (2006). Hydrogen Bond Catalyzed Direct Reductive Amination of Ketones. Organic Letters. 8(4). 741–744. 97 indexed citations
16.
Hassfeld, Jorma, et al.. (2006). The Total Synthesis of (+)-Tedanolide. Journal of the American Chemical Society. 128(43). 14038–14039. 49 indexed citations
17.
Menche, Dirk, et al.. (2006). Hydrogen Bond Catalyzed Direct Reductive Amination of Ketones.. ChemInform. 37(26). 1 indexed citations
18.
Hassfeld, Jorma, Markus Kalesse, Timo Stellfeld, & Mathias Christmann. (2005). Asymmetric Total Synthesis of Complex Marine Natural Products. Advances in biochemical engineering, biotechnology. 97. 133–203. 4 indexed citations
19.
Hassfeld, Jorma, Ulrike Eggert, & Markus Kalesse. (2005). Synthesis of the C1—C17 Macrolactone of Tedanolide (I).. ChemInform. 36(43). 1 indexed citations
20.
Kalesse, Markus & Jorma Hassfeld. (2002). Synthesis of the C1-C11 Segment of Tedanolide via Vinylogous Mukaiyama Aldol Reaction. Synlett. 2007–2010. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026